坏死下垂研究的方法学进展:从挑战到解决方案

Peixing Wan, Jiong Yan, Zhenggang Liu
{"title":"坏死下垂研究的方法学进展:从挑战到解决方案","authors":"Peixing Wan,&nbsp;Jiong Yan,&nbsp;Zhenggang Liu","doi":"10.1016/j.jncc.2022.08.007","DOIUrl":null,"url":null,"abstract":"<div><p>Necroptosis is currently attracting the attention of the scientific community for its broad implications in inflammatory diseases and cancer. However, detecting ongoing necroptosis <em>in vivo</em> under both experimental and clinical disease conditions remains challenging. The technical barrier lies in four aspects, namely tissue sampling, real-time <em>in vivo</em> monitoring, specific markers, and distinction between different types of cell death. In this review, we presented the latest methodological advances for <em>in vivo</em> necroptosis identification. The advances highlighted the multi-parameter flow cytometry, sA5-YFP tool, radiolabeled Annexin V/Duramycin, Gallium-68-labeled IRDye800CW contrast agent, and SMART platform <em>in vivo</em>. We also discussed the up-to-date research models in studying necroptosis, particularly the mice models for manipulating and monitoring necroptosis. Based on these recent advances, this review aims to provide some advice on current necroptosis techniques and approaches.</p></div>","PeriodicalId":73987,"journal":{"name":"Journal of the National Cancer Center","volume":"2 4","pages":"Pages 291-297"},"PeriodicalIF":7.6000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757602/pdf/","citationCount":"2","resultStr":"{\"title\":\"Methodological advances in necroptosis research: From challenges to solutions\",\"authors\":\"Peixing Wan,&nbsp;Jiong Yan,&nbsp;Zhenggang Liu\",\"doi\":\"10.1016/j.jncc.2022.08.007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Necroptosis is currently attracting the attention of the scientific community for its broad implications in inflammatory diseases and cancer. However, detecting ongoing necroptosis <em>in vivo</em> under both experimental and clinical disease conditions remains challenging. The technical barrier lies in four aspects, namely tissue sampling, real-time <em>in vivo</em> monitoring, specific markers, and distinction between different types of cell death. In this review, we presented the latest methodological advances for <em>in vivo</em> necroptosis identification. The advances highlighted the multi-parameter flow cytometry, sA5-YFP tool, radiolabeled Annexin V/Duramycin, Gallium-68-labeled IRDye800CW contrast agent, and SMART platform <em>in vivo</em>. We also discussed the up-to-date research models in studying necroptosis, particularly the mice models for manipulating and monitoring necroptosis. Based on these recent advances, this review aims to provide some advice on current necroptosis techniques and approaches.</p></div>\",\"PeriodicalId\":73987,\"journal\":{\"name\":\"Journal of the National Cancer Center\",\"volume\":\"2 4\",\"pages\":\"Pages 291-297\"},\"PeriodicalIF\":7.6000,\"publicationDate\":\"2022-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757602/pdf/\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the National Cancer Center\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S266700542200062X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the National Cancer Center","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S266700542200062X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 2

摘要

坏死性上睑下垂因其在炎症性疾病和癌症中的广泛意义而引起科学界的关注。然而,在实验和临床疾病条件下检测正在进行的坏死性上睑下垂仍然具有挑战性。技术障碍在于四个方面,即组织取样、活体实时监测、特异性标记、不同类型细胞死亡的区分。在这篇综述中,我们介绍了体内坏死性下垂鉴定的最新方法学进展。这些进展突出了多参数流式细胞术、sA5-YFP工具、放射性标记的膜联蛋白V/Duramycin、镓68标记的IRDye800CW造影剂和SMART体内平台。我们还讨论了研究坏死性上睑下垂的最新研究模型,特别是用于操纵和监测坏死性上睑下垂的小鼠模型。基于这些最新进展,本文综述旨在对目前的坏死下垂技术和方法提供一些建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Methodological advances in necroptosis research: From challenges to solutions

Necroptosis is currently attracting the attention of the scientific community for its broad implications in inflammatory diseases and cancer. However, detecting ongoing necroptosis in vivo under both experimental and clinical disease conditions remains challenging. The technical barrier lies in four aspects, namely tissue sampling, real-time in vivo monitoring, specific markers, and distinction between different types of cell death. In this review, we presented the latest methodological advances for in vivo necroptosis identification. The advances highlighted the multi-parameter flow cytometry, sA5-YFP tool, radiolabeled Annexin V/Duramycin, Gallium-68-labeled IRDye800CW contrast agent, and SMART platform in vivo. We also discussed the up-to-date research models in studying necroptosis, particularly the mice models for manipulating and monitoring necroptosis. Based on these recent advances, this review aims to provide some advice on current necroptosis techniques and approaches.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
14.20
自引率
0.00%
发文量
0
审稿时长
70 days
期刊最新文献
Editorial Board Cancer survival statistics in China 2019–2021: a multicenter, population-based study Associations between blood glucose and early- and late-onset colorectal cancer: evidence from two prospective cohorts and Mendelian randomization analyses Primary liver cancer organoids and their application to research and therapy DCS, a novel classifier system based on disulfidptosis reveals tumor microenvironment heterogeneity and guides frontline therapy for clear cell renal carcinoma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1